查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1801245

2025 年至 2033 年凝块管理设备市场规模、份额、趋势及预测（按产品类型、最终用户和地区）

Clot Management Devices Market Size, Share, Trends and Forecast by Product Type, End-User, and Region, 2025-2033
出版日期: | 出版商: IMARC | 英文 122 Pages | 商品交期: 2-3个工作天内

价格

2024年，全球血栓管理设备市场规模达19亿美元。展望未来， IMARC Group预测，到2033年，该市场规模将达到29亿美元，2025-2033年期间的复合年增长率为4.58%。北美目前占据市场主导地位，2024年将占据超过55.3%的市场。心血管疾病盛行率上升、人口老化、微创手术需求成长以及技术进步是推动血栓管理设备市场份额成长的一些关键因素。

深部静脉血栓、心血管疾病、中风和肺栓塞的发生率不断上升，推动了血栓管理设备市场的发展，也增加了对有效血栓清除解决方案的需求。老年人口的快速成长，更容易患血栓性疾病，进一步刺激了市场的发展。微创手术技术的进步改善了患者的预后，缩短了住院时间和恢復期。人们对血栓早期发现和治疗的认识不断提高，以及优惠的报销政策也推动了相关技术的普及。此外，医疗支出的不断增长、政府对先进医疗技术的支持以及专科治疗中心的扩张也促进了市场的成长。主要医疗器材製造商的存在以及对创新血栓切除技术的持续研究也推动了该行业的竞争格局。

美国血栓管理设备市场受深部静脉栓塞、心血管疾病和肺栓塞的高发病率驱动。美国先进的医疗基础设施、微创手术的日益普及以及领先医疗器材製造商的强大影响力，共同推动了市场的成长。优惠的报销政策和高额的医疗支出提高了人们获得先进治疗的管道。此外，人们对早期血栓检测意识的不断提高、老年人口的增长以及血栓切除设备的技术进步也刺激了需求。例如，2025年1月，Argon Medical Devices 发表了CLEAN-PE研究的首批患者入组情况，该研究旨在评估Cleaner Pro血栓切除系统从确诊为肺栓塞(PE)的患者肺部提取血栓的安全性和有效性。预计将有超过100名患者在美国各地的医院参加CLEAN-PE研究。政府支持、持续研发以及门诊手术数量的增加进一步推动了美国市场的扩张

血块管理设备市场趋势：

心血管疾病和血栓性疾病盛行率上升

心血管疾病、中风、深部静脉栓塞和肺栓塞发病率的不断上升是血栓管理设备市场的主要驱动力。久坐不动的生活方式、肥胖、吸烟和高血压会导致血栓病例增多，因此需要有效的治疗方案。全球人口老化进一步增加了血栓性疾病的风险，增加了对先进血栓清除技术的需求。根据最近的行业报告，到 2024 年，全球 12% 的人口年龄在 60 岁及以上，相当于 12 亿人。预计到 2050 年，这一数字将上升到 21 亿，占世界总人口的 26%。人们对早期诊断和介入的认识不断提高，导致医院和专科诊所越来越多地采用血栓管理设备。这种不断增加的疾病负担持续推动创新血栓清除技术的研究、开发和商业化。

血块管理设备的技术进步

血栓管理设备的持续创新，例如经皮血栓切除系统、导管溶栓和机械血栓切除设备，正在彻底改变病患照护。这些进步使得微创手术成为可能，缩短了恢復时间和住院时间，同时改善了患者的预后。现代化血栓切除设备提高了精准度和效率，使手术更安全、更有效。人工智慧、机器人技术和即时成像进一步促进了血栓清除技术的改进。随着医疗保健提供者寻求更好、更快、更安全的治疗方案，持续的产品开发和监管批准推动了先进血栓管理技术的普及。例如，2024年9月，领先的介入放射学、血管外科、介入性心臟病学和肿瘤学医疗器械解决方案提供商Argon Medical Devices推出了CLEANER VacTM血栓切除系统，该系统旨在从週边静脉血管中清除血栓。一种称为 CLEANER Vac 血栓切除系统的一次性大口径抽吸工具被开发出来，用于快速有效地从血流受限的静脉中清除血块（也称为血栓）。

优惠的医疗政策和报销支持

政府的支持性政策和报销框架使先进的血栓管理治疗更容易获得，从而为血栓管理设备市场带来了积极的前景。包括美国在内的许多国家都为血栓切除术提供了优惠的保险，鼓励更多医院和医疗保健机构采用这些技术。 FDA 等机构的监管批准以及新型血栓管理设备的 CE 标誌认证进一步推动了市场扩张。例如，2023 年 3 月，Penumbra 获得美国食品药物管理局 (FDA) 的批准，推出了革命性的动脉血栓切除系统 Lightning Bolt 7。该技术采用压力感测器和演算法来确定设备吸入的是血液还是血栓，并调节抽吸速度以去除血栓。 Penumbra 位于加州阿拉米达，预计得益于 Lightning Bolt 7 产品和最近推出的另一款血管设备 Lightning Flash，其 2023 年的销售额将成长 23% 至 25%。此外，不断增加的医疗保健支出和医疗基础设施投资为製造商创造了推出创新血栓管理解决方案的机会，确保更广泛的患者能够获得挽救生命的治疗。

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

第五章：全球血块管理设备市场

  • 市场概览
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场区隔：依产品类型

  • 神经血管栓塞切​​除装置
  • 栓塞切除球囊导管
  • 经皮血栓切除装置
    • 主要类型
      • 机械血栓切除术
      • 血栓抽吸术
      • 经皮机械血栓切除术（PMT）
  • 导管直接溶栓装置
  • 下腔静脉过滤器
    • 主要类型
      • 永恆的
      • 可检索

第七章：市场区隔：依最终用户

  • 医院
  • 诊断中心和专科诊所

第八章：市场区隔：依地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲

第九章：SWOT分析

第 10 章：价值链分析

第 11 章：波特五力分析

第 12 章：价格指标

第 13 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • AngioDynamics Inc.
    • Argon Medical Devices Inc.
    • Boston Scientific Corporation
    • DePuy Synthes Inc.
    • Edwards Lifesciences Corporation
    • iVascular SLU
    • Lemaitre Vascular Inc.
    • Medtronic Inc.
    • Straub Medical AG
    • Stryker Corporation
    • Teleflex Incorporated
    • Vascular Solutions
Product Code: SR112025A2131

The global clot management devices market size was valued at USD 1.90 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 2.90 Billion by 2033, exhibiting a CAGR of 4.58% during 2025-2033. North America currently dominates the market, holding a significant market share of over 55.3% in 2024. The rising prevalence of cardiovascular diseases, an aging population, increasing demand for minimally invasive procedures, and technological advancements are some of the key factors fueling the clot management devices market share.

The market for clot management devices is driven by the rising prevalence of deep vein thrombosis, cardiovascular diseases, stroke, and pulmonary embolism, which increase the demand for effective clot removal solutions. A rapidly increasing geriatric population, more susceptible to thrombotic disease, fuels the market further. Advances in technology for minimally invasive procedures improve patient outcomes with shorter hospital stays and recovery periods. Greater awareness of early detection and treatment of clots and favorable reimbursement practices drive adoption. Additionally, rising healthcare expenditures, government support for advanced medical technologies, and the expansion of specialized treatment centers contribute to market growth. The presence of key medical device manufacturers and ongoing research into innovative thrombectomy techniques also drive the industry's competitive landscape.

The market for clot management devices in the United States is driven by the high prevalence of deep vein thrombosis, cardiovascular diseases, and pulmonary embolism. The country's advanced healthcare infrastructure, increasing adoption of minimally invasive procedures, and strong presence of leading medical device manufacturers contribute to market growth. Favorable reimbursement policies and high healthcare spending enhance access to advanced treatments. Additionally, rising awareness about early clot detection, a growing geriatric population, and technological advancements in thrombectomy devices fuel demand. For instance, in January 2025, Argon Medical Devices reported the initial patient enrollment in the CLEAN-PE study, which seeks to assess the safety and effectiveness of the Cleaner Pro thrombectomy system for extracting blood clots from the lungs of patients diagnosed with pulmonary embolism (PE). It is anticipated that more than 100 patients are enrolled in CLEAN-PE at different hospitals throughout the United States. Government support, ongoing research and development, and an increasing number of outpatient procedures further propel the market's expansion in the U.S.

Clot Management Devices Market Trends:

Rising Prevalence of Cardiovascular Diseases and Thrombotic Disorders

The increasing incidence of cardiovascular diseases, stroke, deep vein thrombosis, and pulmonary embolism is a major driver of the clot management devices market. Sedentary lifestyles, obesity, smoking, and hypertension contribute to higher cases of blood clots, necessitating effective treatment solutions. An aging global population further escalates the risk of thrombotic disorders, increasing demand for advanced clot removal technologies. According to recent industry reports, in 2024, 12% of the global population was aged 60 years and above, equating to 1.2 Billion individuals. This number is expected to rise to 2.1 Billion by 2050, making up 26% of the total population in the world. The growing awareness about early diagnosis and intervention has led to higher adoption of clot management devices in hospitals and specialized clinics. This rising disease burden continues to push the research, development, and commercialization of innovative clot removal technologies.

Technological Advancements in Clot Management Devices

Ongoing innovations in clot management devices, such as percutaneous thrombectomy systems, catheter-directed thrombolysis, and mechanical thrombectomy devices, are revolutionizing patient care. These advancements allow for minimally invasive procedures, reducing recovery time and hospital stays while improving patient outcomes. Modern thrombectomy devices offer enhanced precision and efficiency, making procedures safer and more effective. Artificial intelligence, robotics, and real-time imaging further contribute to improved clot removal techniques. As healthcare providers seek better, faster, and safer treatment options, continuous product development and regulatory approvals drive the adoption of advanced clot management technologies. For instance, in September 2024, The CLEANER VacTM Thrombectomy System, which is intended to remove blood clots from the peripheral venous vasculature, was introduced by Argon Medical Devices, a leading provider of medical device solutions for interventional radiology, vascular surgery, interventional cardiology, and oncology procedures. A single-use, large-bore aspiration tool called the CLEANER Vac Thrombectomy System was developed to quickly and effectively remove blood clots, also known as thrombus, from veins with restricted blood flow.

Favorable Healthcare Policies and Reimbursement Support

Supportive government policies and reimbursement frameworks create a positive clot management devices market outlook by making advanced clot management treatments more accessible. Many countries, including the United States, offer favorable insurance coverage for thrombectomy procedures, encouraging more hospitals and healthcare providers to adopt these technologies. Regulatory approvals from agencies like the FDA and CE mark certification for new clot management devices further drive market expansion. For instance, in March 2023, Penumbra received approval from the Food and Drug Administration to introduce Lightning Bolt 7, a revolutionary arterial thrombectomy system. The technology employs pressure sensors and an algorithm to determine whether the device is pulling in blood or a clot and modulates aspiration to remove blood clots. Penumbra, situated in Alameda, California, anticipates a 23% to 25% increase in sales in 2023 due to the Lightning Bolt 7 product and the recent introduction of Lightning Flash, another vascular device. Additionally, increasing healthcare expenditures and investments in medical infrastructure create opportunities for manufacturers to introduce innovative clot management solutions, ensuring broader patient access to life-saving treatments.

Clot Management Devices Industry Segmentation:

Analysis by Product Type:

  • Neurovascular Embolectomy Devices
  • Embolectomy Balloon Catheters
  • Percutaneous Thrombectomy Devices
    • Mechanical Thrombectomy
    • Aspiration Thrombectomy
    • Percutaneous Mechanical Thrombectomy (PMT)
  • Catheter-Directed Thrombolysis Devices
  • Inferior Vena Cava Filters
    • Permanent
    • Retrievable

Percutaneous thrombectomy devices stand as the largest product type in 2024, holding around 37.6% of the market due to their effectiveness in rapidly removing blood clots with minimal invasiveness. These devices are widely used in treating deep vein thrombosis, pulmonary embolism, and arterial thrombosis, reducing the risk of complications and improving patient outcomes. Advancements in technology have enhanced their precision and efficiency, making them a preferred choice among healthcare professionals. Additionally, the growing prevalence of cardiovascular diseases, an aging population, and increasing demand for faster recovery times further drive their adoption. Their ability to minimize hospital stays and healthcare costs also boosts market growth.

Analysis by End-User:

  • Hospitals
  • Diagnostic Centers and Specialty Clinics

Hospitals leads the market with around 80.9% of market share in 2024 due to their advanced infrastructure, skilled healthcare professionals, and ability to handle complex thrombectomy procedures. They offer a wide range of clot management treatments, including percutaneous thrombectomy, catheter-directed thrombolysis, and surgical thrombectomy, ensuring comprehensive patient care. The increasing prevalence of cardiovascular diseases and emergency cases requiring immediate clot removal further drive demand. Additionally, hospitals have better access to cutting-edge medical technologies and government funding, enhancing treatment efficiency. The rising number of hospital admissions for thrombotic disorders and the availability of reimbursement policies also contribute to their market dominance.

Regional Analysis:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

In 2024, North America accounted for the largest market share of over 55.3%. The clot management devices demand in North America is influenced by the high prevalence of cardiovascular diseases, stroke, deep vein thrombosis, and pulmonary embolism. The region's advanced healthcare infrastructure, strong presence of key medical device manufacturers, and increasing adoption of minimally invasive procedures contribute to market growth. Favorable reimbursement policies, high healthcare spending, and government support for advanced medical technologies further enhance accessibility. Additionally, rising awareness of early clot detection and treatment, coupled with a growing geriatric population prone to thrombotic disorders, fuels demand. Technological advancements and an increasing number of outpatient procedures also play a significant role.

Key Regional Takeaways:

United States Clot Management Devices Market Analysis

In 2024, the United States accounted for over 89.80% of the clot management devices market in North America. The United States clot management devices market is primarily driven by the rising incidence of cardiovascular diseases, such as deep vein thrombosis (DVT), pulmonary embolism (PE), and stroke, driven by an increasing geriatric population and growing obesity rates. According to the Population Reference Bureau, the number of individuals aged 65 and above in the United States will reach 82 million by 2050, accounting for 23% of the population of the country. Moreover, the prevalence of atrial fibrillation, a key risk factor for thromboembolic events, is also rising, propelling the need for advanced clot removal solutions. Technological advancements in thrombectomy and embolectomy devices, such as catheter-directed thrombolysis and aspiration thrombectomy, are also improving procedural efficiency and patient outcomes, fueling adoption in hospitals and ambulatory surgical centers. Additionally, the growing preference for minimally invasive procedures over conventional surgical interventions is further contributing to industry expansion, as these devices reduce complications, hospital stays, and recovery times. Favorable reimbursement policies and guidelines from organizations such as the American Heart Association (AHA) and the U.S. Food and Drug Administration (FDA) further support the adoption of innovative clot management technologies. Besides this, expanding clinical research on novel clot management approaches is expected to further propel industry advancements.

Asia Pacific Clot Management Devices Market Analysis

The Asia Pacific clot management devices market is growing due to rising cases of atrial fibrillation and hypertension, both significant risk factors for thromboembolic disorders. Moreover, the increasing prevalence of cardiovascular diseases and venous thromboembolism (VTE), driven by aging populations, rising urbanization, and lifestyle-related risk factors such as diabetes, is also propelling the market. According to industry reports, 52.9% of the total population of Asia lived in urban areas in 2024, equating to 2,545,230,547 individuals. Additionally, rising awareness about stroke prevention and early treatment, driven by national health programs, is also encouraging the adoption of advanced clot removal technologies. Furthermore, the expansion of private healthcare facilities and the increasing presence of multinational medical device companies in emerging markets are improving access to cutting-edge thrombectomy and embolectomy solutions. Growing disposable incomes and improved insurance coverage are also making high-cost clot management procedures more accessible, supporting overall market growth.

Europe Clot Management Devices Market Analysis

The Europe clot management devices market is experiencing growth, fueled by the increasing prevalence of thromboembolic disorders, driven by aging demographics and sedentary lifestyles. The growing burden of non-communicable diseases, including hypertension, diabetes, and cardiovascular disorders, further elevates the risk of thromboembolic events. According to the World Health Organization (WHO), cardiovascular diseases (CVDs) account for more than 42.5% of all deaths each year in Europe, making them the leading cause of premature death in the region. The widespread implementation of national stroke prevention programs and guidelines by organizations such as the European Society of Cardiology (ESC) and the European Stroke Organisation (ESO) is driving the adoption of advanced thrombectomy and thrombolysis devices. Increasing healthcare investments across Europe, particularly in digital health integration and AI-powered clot detection technologies, is further improving diagnosis and treatment precision. Additionally, the rising number of stroke centers and specialized vascular care units across countries such as Germany, the UK, France, and Italy is also boosting demand for advanced clot management technologies. Increasing awareness campaigns and training programs for healthcare professionals on thromboembolic disease management are further driving adoption. The rise in surgical procedures, particularly orthopedic and cancer-related surgeries, is also leading to a higher incidence of post-operative blood clots, propelling the need for effective clot management solutions.

Latin America Clot Management Devices Market Analysis

The Latin America clot management devices market is expanding due to the increasing prevalence of hypertension and metabolic disorders, which elevate the risk of thromboembolic events. Growing healthcare expenditure and government initiatives aimed at improving stroke care are enhancing access to advanced thrombectomy and thrombolysis procedures. For instance, as per the International Trade Administration (ITA), 9.47% of the GDP of Brazil is spent on healthcare, making it the largest market for healthcare in Latin America. The expansion of private hospitals and specialized stroke centers, particularly in Brazil, Mexico, and Argentina, is further supporting market growth. According to the ITA, 62% of the hospitals in Brazil are private. Besides this, strengthening regulatory frameworks and faster approval processes are also facilitating the introduction of new clot removal technologies in the region.

Middle East and Africa Clot Management Devices Market Analysis

The Middle East and Africa clot management devices market is propelled by an increasing geriatric population and a higher incidence of risk factors such as hypertension and dyslipidemia, increasing the likelihood of thromboembolic events. Expanding health insurance coverage and government subsidies in countries such as Saudi Arabia and the UAE are improving access to advanced clot removal procedures. For instance, according to the International Trade Administration, the Saudi Arabian government intends to invest more than USD 65 billion under Vision 2030 to build the nation's healthcare system and restructure and privatize insurance and health care. Additionally, local manufacturing initiatives and partnerships with international medical device companies are improving product availability and affordability. Growing medical tourism in the region is further supporting the adoption of advanced clot management technologies.

Competitive Landscape:

The market for clot management devices is extremely competitive, and major competitors are concentrating on product improvements, strategic mergers, and technology breakthroughs to improve their market positions. Major companies like Medtronic, Boston Scientific, Terumo Corporation, and Abbott Laboratories dominate the industry with a broad product portfolio and global presence. Startups and mid-sized firms are also entering the market, introducing novel minimally invasive solutions. Collaborations with healthcare providers and research institutions drive innovation. Regulatory approvals, reimbursement policies, and clinical trial success significantly impact market dynamics. Companies compete based on product efficacy, pricing, and distribution networks, making innovation and strategic expansion crucial.

The report provides a comprehensive analysis of the competitive landscape in the clot management devices market with detailed profiles of all major companies, including:

  • AngioDynamics Inc.
  • Argon Medical Devices Inc.
  • Boston Scientific Corporation
  • DePuy Synthes Inc.
  • Edwards Lifesciences Corporation
  • iVascular S.L.U.
  • Lemaitre Vascular Inc.
  • Medtronic Inc.
  • Straub Medical AG
  • Stryker Corporation
  • Teleflex Incorporated
  • Vascular Solutions

Key Questions Answered in This Report

  • 1.How big is the clot management devices market?
  • 2.What is the future outlook of the clot management devices market?
  • 3.What are the key factors driving the clot management devices market?
  • 4.Which region accounts for the largest clot management devices market share?
  • 5.Which are the leading companies in the global clot management devices market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Clot Management Devices Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Neurovascular Embolectomy Devices
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Embolectomy Balloon Catheters
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Percutaneous Thrombectomy Devices
    • 6.3.1 Market Trends
    • 6.3.2 Major Types
      • 6.3.2.1 Mechanical Thrombectomy
      • 6.3.2.2 Aspiration Thrombectomy
      • 6.3.2.3 Percutaneous Mechanical Thrombectomy (PMT)
    • 6.3.3 Market Forecast
  • 6.4 Catheter-Directed Thrombolysis Devices
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Inferior Vena Cava Filters
    • 6.5.1 Market Trends
    • 6.5.2 Major Types
      • 6.5.2.1 Permanent
      • 6.5.2.2 Retrievable
    • 6.5.3 Market Forecast

7 Market Breakup by End-User

  • 7.1 Hospitals
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Diagnostic Centers and Specialty Clinics
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Indicators

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 AngioDynamics Inc.
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 Argon Medical Devices Inc.
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
    • 13.3.3 Boston Scientific Corporation
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
      • 13.3.3.4 SWOT Analysis
    • 13.3.4 DePuy Synthes Inc.
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
    • 13.3.5 Edwards Lifesciences Corporation
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
    • 13.3.6 iVascular S.L.U.
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 Financials
    • 13.3.7 Lemaitre Vascular Inc.
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
      • 13.3.7.3 Financials
      • 13.3.7.4 SWOT Analysis
    • 13.3.8 Medtronic Inc.
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
    • 13.3.9 Straub Medical AG
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
    • 13.3.10 Stryker Corporation
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
      • 13.3.10.3 Financials
      • 13.3.10.4 SWOT Analysis
    • 13.3.11 Teleflex Incorporated
      • 13.3.11.1 Company Overview
      • 13.3.11.2 Product Portfolio
      • 13.3.11.3 Financials
      • 13.3.11.4 SWOT Analysis
    • 13.3.12 Vascular Solutions
      • 13.3.12.1 Company Overview
      • 13.3.12.2 Product Portfolio

List of Figures

  • Figure 1: Global: Clot Management Devices Market: Major Drivers and Challenges
  • Figure 2: Global: Clot Management Devices Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Clot Management Devices Market: Breakup by Product Type (in %), 2024
  • Figure 4: Global: Clot Management Devices Market: Breakup by End-User (in %), 2024
  • Figure 5: Global: Clot Management Devices Market: Breakup by Region (in %), 2024
  • Figure 6: Global: Clot Management Devices Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 7: Global: Clot Management Devices (Neurovascular Embolectomy Devices) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 8: Global: Clot Management Devices (Neurovascular Embolectomy Devices) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 9: Global: Clot Management Devices (Embolectomy Balloon Catheters) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Clot Management Devices (Embolectomy Balloon Catheters) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Clot Management Devices (Percutaneous Thrombectomy Devices) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Clot Management Devices (Percutaneous Thrombectomy Devices) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Clot Management Devices (Catheter-Directed Thrombolysis Devices) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Clot Management Devices (Catheter-Directed Thrombolysis Devices) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Clot Management Devices (Inferior Vena Cava Filters) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Clot Management Devices (Inferior Vena Cava Filters) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Clot Management Devices (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Clot Management Devices (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Clot Management Devices (Diagnostic Centers and Specialty Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Clot Management Devices (Diagnostic Centers and Specialty Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: North America: Clot Management Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: North America: Clot Management Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: United States: Clot Management Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: United States: Clot Management Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Canada: Clot Management Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Canada: Clot Management Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Asia Pacific: Clot Management Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Asia Pacific: Clot Management Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: China: Clot Management Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: China: Clot Management Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: Japan: Clot Management Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: Japan: Clot Management Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: India: Clot Management Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: India: Clot Management Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: South Korea: Clot Management Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: South Korea: Clot Management Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: Australia: Clot Management Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: Australia: Clot Management Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: Indonesia: Clot Management Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: Indonesia: Clot Management Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: Others: Clot Management Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: Others: Clot Management Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: Europe: Clot Management Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: Europe: Clot Management Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: Germany: Clot Management Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: Germany: Clot Management Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: France: Clot Management Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: France: Clot Management Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: United Kingdom: Clot Management Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: United Kingdom: Clot Management Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: Italy: Clot Management Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: Italy: Clot Management Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: Spain: Clot Management Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: Spain: Clot Management Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: Russia: Clot Management Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: Russia: Clot Management Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: Others: Clot Management Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Others: Clot Management Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: Latin America: Clot Management Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: Latin America: Clot Management Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Brazil: Clot Management Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Brazil: Clot Management Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: Mexico: Clot Management Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: Mexico: Clot Management Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: Others: Clot Management Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: Others: Clot Management Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: Middle East and Africa: Clot Management Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: Middle East and Africa: Clot Management Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: Global: Clot Management Devices Industry: SWOT Analysis
  • Figure 70: Global: Clot Management Devices Industry: Value Chain Analysis
  • Figure 71: Global: Clot Management Devices Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Clot Management Devices Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Clot Management Devices Market Forecast: Breakup by Product Type (in Million USD), 2025-2033
  • Table 3: Global: Clot Management Devices Market Forecast: Breakup by End-User (in Million USD), 2025-2033
  • Table 4: Global: Clot Management Devices Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 5: Global: Clot Management Devices Market Structure
  • Table 6: Global: Clot Management Devices Market: Key Players